Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Catalyst Pharm Inc (CPRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Market Trends Toward New Normal in AllianceBernstein Holding, Five9, Simpson Manufacturing, Green Plains, Catalyst Pharmaceuticals, and Commercial Vehicle Group -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of AllianceBernstein Holding L.P....

AB : 29.87 (-2.54%)
SSD : 60.96 (-3.04%)
CVGI : 7.44 (-1.20%)
FIVN : 38.88 (-2.58%)
CPRX : 3.35 (-3.74%)
GPRE : 18.35 (-2.39%)
Catalyst Pharmaceuticals (CPRX) Catches Eye: Stock Jumps 6.3%

Catalyst Pharmaceuticals (CPRX) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

CPRX : 3.35 (-3.74%)
PCRX : 48.21 (+0.35%)
Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences

-- Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease on September 25-27 in New York City

CPRX : 3.35 (-3.74%)
Catalyst (CPRX) Up 16% Since Last Earnings Report: Can It Continue?

Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CPRX : 3.35 (-3.74%)
Catalyst Pharmaceuticals to Present at Rodman & Renshaw's 20th Annual Global Investment Conference

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...

CPRX : 3.35 (-3.74%)
Catalyst (CPRX) Posts Narrower-Than-Expected Loss in Q2

The FDA accepts Catalyst's (CPRX) NDA for its lead pipeline candidate, Firdapse, for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) and an action date of Nov 28, 2018 is set for the same.

VRTX : 178.90 (-3.55%)
SGEN : 73.72 (-1.18%)
CPRX : 3.35 (-3.74%)
GLPG : 105.10 (+1.50%)
Catalyst Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Catalyst Pharmaceuticals, Inc. (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 8:30:00 AM Eastern...

CPRX : 3.35 (-3.74%)
Catalyst Pharmaceuticals Expands Commercial Leadership Team

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...

CPRX : 3.35 (-3.74%)
What's in Store for Catalyst (CPRX) This Earnings Season?

Investors' focus will be on Catalyst's (CPRX) pipeline candidates, Firdapse and CPP-115, and regulatory updates, during the second-quarter earnings call.

ENDP : 17.54 (+2.87%)
JAZZ : 156.00 (-1.80%)
CPRX : 3.35 (-3.74%)
PCRX : 48.21 (+0.35%)
BeyondSpring Appoints Richard J. Daly as Chief Operating Officer to Lead the Transition to Commercialization

BeyondSpring Inc. (NASDAQ:BYSI) ("BeyondSpring" or the "Company"), a global, clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies, announced today the appointment...

CUR : 0.94 (-6.00%)
BYSI : 19.85 (+3.39%)
CPRX : 3.35 (-3.74%)
Catalyst (CPRX) Posts In-Line Q1 Loss, Pipeline Progresses

Catalyst reported in-line loss in Q1. The company resubmitted a new drug application for its lead candidate Firdapse and expects FDA to accept the NDA in Q2.

LGND : 197.06 (-2.93%)
CATB : 0.69 (+7.81%)
ENTA : 78.84 (-2.51%)
CPRX : 3.35 (-3.74%)
Catalyst Pharmaceuticals Announces First Quarter 2018 Financial Results and Provides Corporate Update

Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological...

CPRX : 3.35 (-3.74%)
What's in Store for Catalyst (CPRX) This Earnings Season?

Catalyst (CPRX) is expected to report first-quarter 2018 results on May 9, after the market closesa and investor's focus will be on pipeline and regulatory updates during the earnings call.

CELG : 82.95 (-1.58%)
ADVM : 4.70 (-6.75%)
EBS : 61.70 (-2.03%)
CPRX : 3.35 (-3.74%)
Catalyst Pharmaceuticals to Hold First Quarter Financial Results and Corporate Update Conference Call and Webcast on Thursday, May 10th, 2018

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...

CPRX : 3.35 (-3.74%)
Catalyst Pharmaceuticals Introduces New Corporate Website

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...

CPRX : 3.35 (-3.74%)
Catalyst Enrolls First Patient in Phase III Firdapse Study

Catalyst (CPRX) enrolls the first patient in its phase III clinical trial (MSK-002) to evaluate the efficacy and safety of Firdapse in patients with MuSK antibody positive Myasthenia Gravis.

PTGX : 8.82 (-3.71%)
LGND : 197.06 (-2.93%)
BMRN : 103.82 (-2.12%)
CPRX : 3.35 (-3.74%)
Report: Developing Opportunities within Clean Energy Fuels, Catalyst Pharmaceuticals, Qorvo, Brunswick, DCT Industrial Trust, and Radius Health -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Clean Energy Fuels Corp. (NASDAQ:CLNE),...

BC : 59.72 (-2.48%)
DCT : 66.28 (-3.96%)
RDUS : 19.48 (-1.91%)
CPRX : 3.35 (-3.74%)
QRVO : 73.40 (-2.68%)
CLNE : 2.40 (+0.84%)
Catalyst Pharmaceuticals Announces Enrollment of First Patient in Phase 3 Trial of Firdapse(R) in MuSK Antibody Positive Myasthenia Gravis

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...

CPRX : 3.35 (-3.74%)
Catalyst Pharmaceuticals (CPRX) Down 7.4% Since Earnings Report: Can It Rebound?

Catalyst Pharmaceuticals (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CPRX : 3.35 (-3.74%)
Catalyst (CPRX) Up on New Drug Application for Firdapse

Catalyst (CPRX) new drug application for its lead pipeline candidate keeps it on a growth trajectory.

LGND : 197.06 (-2.93%)
BMRN : 103.82 (-2.12%)
REGN : 395.22 (-0.96%)
CPRX : 3.35 (-3.74%)

Van Meerten Stock Picks

Tesla According to Peter Lynch
Today's Barchart Chart of the Day will be the auto maker Tesla (TSLA).
TSLA -7.87
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

cmdty Insider - Ag Market Commentary

Today's Commentary

Corn futures saw losses of 2 to 3 1/2 cents in most contracts on Thursday, pressured by a disappointing export sales number. This morning’s USDA Export Sales report indicated that 18/19 sales in the week of 10/11 totaled just 382,534 MT. That w...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar